Open AccessComparisons of survival outcomes between bevacizumab and olaparib inBRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
Author(s) -
Se Ik Kim,
Jeong Won Lee,
Kidong Kim,
Maria Lee,
Ji Geun Yoo,
Min Chul Choi,
Suhyun Hwangbo,
Young Lan Kwak,
Jong Min Lee,
So Jin Shin,
Seongbo Shim,
Min Kyu Kim
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e90
Subject(s) - medicine , bevacizumab , hazard ratio , olaparib , oncology , brca mutation , ovarian cancer , gynecologic oncology , propensity score matching , confidence interval , carboplatin , progression free survival , chemotherapy , cancer , cisplatin , gene , biochemistry , chemistry , polymerase , poly adp ribose polymerase